IGF2BP1 has been reported to execute an m6A-dependent modification of lncRNA differentiation antagonizing nonprotein coding RNA (DANCR) which contributes to the tumorigenesis of multiple cancers and favors the oncogenicity of pancreatic cancer [42,43]. The gene discussed is IGF2BP1; the disease is pancreatic neoplasm.